May 8, 2019
NYSCF Research Institute
CRISPR gene editing has revolutionized biomedical research by allowing scientists to precisely manipulate the DNA of human cells. This technology has created unprecedented opportunities to understand the genetic basis of disease—and even to cure certain diseases—while also opening up questions about how to ensure it is used safely and ethically.
This panel discussion was moderated by Raeka Aiyar, PhD (NYSCF Senior Director of Scientific Outreach), and featured panelists Susan L. Solomon, JD (NYSCF CEO), Jeffrey Kahn, PhD, MPH (Andreas C. Dracopoulos Director of the Berman Institute), Betsy Myers, PhD (Program Director for Medical Research at the Doris Duke Charitable Foundation), and Neville Sanjana, PhD (Core Faculty Member of the New York Genome Center and Assistant Professor at New York University).
Watch this video to learn more about:
What gene editing is (0:00)
How gene editing can be used to study and treat disease (4:05)
The bioethical issues gene editing presents (7:49)
The ethics of the “CRISPR babies” (12:39)
Gene therapies for sickle cell anemia (15:01 & 20:19)
What should be considered when deciding when gene editing is appropriate (17:12)
Using CRISPR to understand the genome (22:42)
The combination of stem cells, automation, and gene editing (24:37)